세계의 수족 증후군 시장 보고서(2025년)

Hand foot syndrome, also known as palmar-plantar erythrodysesthesia, is a condition triggered by chemotherapy or certain medications. It leads to redness, swelling, pain, and peeling on the palms of the hands and the soles of the feet. In more severe cases, blisters and ulcerations may develop, impacting daily activities.

The primary treatments for hand foot syndrome include both systemic and topical options. Systemic treatments involve medications that work throughout the body to relieve symptoms and prevent complications. These treatments are utilized in various fields such as oncology, dermatology, and others, and are typically administered in hospitals, clinics, and homecare settings.

The hand foot syndrome market research report is one of a series of new reports from The Business Research Company that provides hand foot syndrome market statistics, including the hand foot syndrome industry's global market size, regional shares, competitors with a hand foot syndrome market share, detailed hand foot syndrome market segments, market trends and opportunities, and any further data you may need to thrive in the hand foot syndrome industry. This hand foot syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hand foot syndrome market size has grown strongly in recent years. It will grow from $0.48 billion in 2024 to $0.52 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth during the historic period can be attributed to the rising prevalence of chronic diseases, an increase in global cancer diagnoses, a growing emphasis on patient-centered cancer care, higher government initiatives and healthcare funding, and a growing focus by pharmaceutical companies on rare and orphan diseases.

The hand foot syndrome market size is expected to see strong growth in the next few years. It will grow to $0.67 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecast period can be attributed to the increasing emphasis on palliative and symptom management care, growth in oncology biopharmaceuticals, a rise in clinical trials for HFS treatments, increasing demand for oral and at-home treatments, and a global increase in health insurance coverage. Key trends expected in this period include the integration of virtual reality (VR) for symptom management, advancements in wearable health devices, the use of CRISPR technology for gene editing and personalized treatments, the development of AI-powered predictive tools, and the application of 3D imaging for better understanding of skin conditions.

The rising incidence of cancer is expected to drive the growth of the hand-foot syndrome market. Cancer is a condition characterized by uncontrolled cell growth that spreads to other parts of the body. The increasing number of cancer cases is influenced by factors such as aging populations, lifestyle changes, environmental exposures, and advancements in detection methods. As cancer cases rise, chemotherapy usage also increases, leading to a higher prevalence of hand-foot syndrome, which is a common side effect of chemotherapy treatments. For example, in August 2024, Macmillan Cancer Support, a UK-based charity, reported that over 3 million people in the UK were living with cancer. This figure is projected to rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As a result, the growing number of cancer cases will contribute to the expansion of the hand-foot syndrome market.

Companies operating in the hand-foot syndrome market are focusing on technological innovations such as image-guided radiotherapy (IGRT) to improve the precision and effectiveness of treatments, enhance patient outcomes, and minimize damage to healthy tissues. IGRT uses advanced imaging techniques to ensure accurate tumor targeting during radiation therapy, allowing real-time tracking and adjustment of the tumor's position. For instance, in May 2022, Elekta AB, a Sweden-based medical technology company, introduced the Elekta Esprit, a next-generation radiosurgery system that improves the capabilities of stereotactic radiosurgery. The Elekta Esprit integrates various innovations into a single platform, offering superior visualization and remote accessibility for treatment teams. It also supports flexible workflows, accommodating single-session, fractionated, adaptive, or staged protocols, all designed to improve efficiency and ease of use in clinical environments.

In June 2024, AstraZeneca Plc, a UK-based pharmaceutical company, acquired Fusion Pharmaceuticals Inc. for $2.5 billion. This acquisition aims to strengthen AstraZeneca's oncology portfolio with advanced radiopharmaceuticals, such as FPI-2265, enhance its research and development and manufacturing capabilities, and accelerate the transition to targeted cancer therapies while expanding its presence in Canada. Fusion Pharmaceuticals Inc. is a biotechnology company based in Canada that specializes in developing next-generation radiopharmaceuticals as precision medicines for cancer treatment.

Major players in the hand foot syndrome market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Fresenius Kabi AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., UCB Pharma SA, and Eisai Co. Ltd.

Asia-Pacific was the largest region in the hand food syndrome market in 2024. The regions covered in hand foot syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hand foot syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hand foot syndrome market consists of revenues earned by entities providing services such as treatments, therapies, and supportive care services for managing symptoms and complications of the condition. The market value includes the value of related goods sold by the service provider or included within the service offering. The hand foot syndrome market also includes sales of pharmaceutical drugs, topical treatments, and medical devices used to alleviate symptoms and manage the condition. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hand Foot Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hand foot syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hand foot syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hand foot syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Systemic Treatment; Topical Treatment
• 2) By Application: Oncology; Dermatology; Other Applications
• 3) By End-User: Hospitals; Clinics; Homecare Settings
• Subsegments:
• 1) By Systemic Treatment: Corticosteroids; Analgesics; Anti-Inflammatory Drugs
• 2) By Topical Treatment: Urea-Based Creams; Corticosteroid Creams; Moisturizers; Cooling Gels
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hand Foot Syndrome Market Characteristics

3. Hand Foot Syndrome Market Trends And Strategies

4. Hand Foot Syndrome Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hand Foot Syndrome Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hand Foot Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hand Foot Syndrome Market Growth Rate Analysis
• 5.4. Global Hand Foot Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hand Foot Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hand Foot Syndrome Total Addressable Market (TAM)

6. Hand Foot Syndrome Market Segmentation

• 6.1. Global Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Systemic Treatment
• Topical Treatment
• 6.2. Global Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Dermatology
• Other Applications
• 6.3. Global Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare Settings
• 6.4. Global Hand Foot Syndrome Market, Sub-Segmentation Of Systemic Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Analgesics
• Anti-Inflammatory Drugs
• 6.5. Global Hand Foot Syndrome Market, Sub-Segmentation Of Topical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Urea-Based Creams
• Corticosteroid Creams
• Moisturizers
• Cooling Gels

7. Hand Foot Syndrome Market Regional And Country Analysis

• 7.1. Global Hand Foot Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hand Foot Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hand Foot Syndrome Market

• 8.1. Asia-Pacific Hand Foot Syndrome Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hand Foot Syndrome Market

• 9.1. China Hand Foot Syndrome Market Overview
• 9.2. China Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hand Foot Syndrome Market

• 10.1. India Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hand Foot Syndrome Market

• 11.1. Japan Hand Foot Syndrome Market Overview
• 11.2. Japan Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hand Foot Syndrome Market

• 12.1. Australia Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hand Foot Syndrome Market

• 13.1. Indonesia Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hand Foot Syndrome Market

• 14.1. South Korea Hand Foot Syndrome Market Overview
• 14.2. South Korea Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hand Foot Syndrome Market

• 15.1. Western Europe Hand Foot Syndrome Market Overview
• 15.2. Western Europe Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hand Foot Syndrome Market

• 16.1. UK Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hand Foot Syndrome Market

• 17.1. Germany Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hand Foot Syndrome Market

• 18.1. France Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hand Foot Syndrome Market

• 19.1. Italy Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hand Foot Syndrome Market

• 20.1. Spain Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hand Foot Syndrome Market

• 21.1. Eastern Europe Hand Foot Syndrome Market Overview
• 21.2. Eastern Europe Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hand Foot Syndrome Market

• 22.1. Russia Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hand Foot Syndrome Market

• 23.1. North America Hand Foot Syndrome Market Overview
• 23.2. North America Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hand Foot Syndrome Market

• 24.1. USA Hand Foot Syndrome Market Overview
• 24.2. USA Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hand Foot Syndrome Market

• 25.1. Canada Hand Foot Syndrome Market Overview
• 25.2. Canada Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hand Foot Syndrome Market

• 26.1. South America Hand Foot Syndrome Market Overview
• 26.2. South America Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hand Foot Syndrome Market

• 27.1. Brazil Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hand Foot Syndrome Market

• 28.1. Middle East Hand Foot Syndrome Market Overview
• 28.2. Middle East Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hand Foot Syndrome Market

• 29.1. Africa Hand Foot Syndrome Market Overview
• 29.2. Africa Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hand Foot Syndrome Market Competitive Landscape And Company Profiles

• 30.1. Hand Foot Syndrome Market Competitive Landscape
• 30.2. Hand Foot Syndrome Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Hand Foot Syndrome Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca PLC
• 31.5. Novartis International AG
• 31.6. Fresenius Kabi AG
• 31.7. GlaxoSmithKline plc
• 31.8. Takeda Pharmaceutical Company Limited
• 31.9. Eli Lilly and Company
• 31.10. Gilead Sciences Inc.
• 31.11. Amgen Inc.
• 31.12. Regeneron Pharmaceuticals Inc.
• 31.13. Astellas Pharma Inc.
• 31.14. UCB Pharma SA
• 31.15. Eisai Co. Ltd.

32. Global Hand Foot Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hand Foot Syndrome Market

34. Recent Developments In The Hand Foot Syndrome Market

35. Hand Foot Syndrome Market High Potential Countries, Segments and Strategies

• 35.1 Hand Foot Syndrome Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hand Foot Syndrome Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hand Foot Syndrome Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer